Head to Head Analysis: Kingsoft Cloud (NASDAQ:KC) and Portage Biotech (NASDAQ:ALP)

Portage Biotech (NASDAQ:ALP – Get Free Report) and Kingsoft Cloud (NASDAQ:KC – Get Free Report) are both technology companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, valuation, earnings, analyst recommendations, risk, institutional ownership and dividends.

Earnings & Valuation

This table compares Portage Biotech and Kingsoft Cloud”s gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Portage Biotech $100,000.00 52.08 -$38.63 million ($409.00) -0.01
Kingsoft Cloud $1.37 billion 1.80 -$133.88 million ($0.28) -29.06

Portage Biotech has higher earnings, but lower revenue than Kingsoft Cloud. Kingsoft Cloud is trading at a lower price-to-earnings ratio than Portage Biotech, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Portage Biotech and Kingsoft Cloud’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Portage Biotech N/A N/A N/A
Kingsoft Cloud -5.49% -7.85% -2.41%

Analyst Ratings

This is a breakdown of recent recommendations and price targets for Portage Biotech and Kingsoft Cloud, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Portage Biotech 1 2 0 0 1.67
Kingsoft Cloud 1 0 4 1 2.83

Portage Biotech currently has a consensus target price of $12.50, indicating a potential upside of 272.02%. Kingsoft Cloud has a consensus target price of $16.67, indicating a potential upside of 104.83%. Given Portage Biotech’s higher probable upside, research analysts clearly believe Portage Biotech is more favorable than Kingsoft Cloud.

Institutional & Insider Ownership

13.4% of Portage Biotech shares are owned by institutional investors. Comparatively, 13.4% of Kingsoft Cloud shares are owned by institutional investors. 14.2% of Kingsoft Cloud shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Volatility and Risk

Portage Biotech has a beta of 0.65, suggesting that its stock price is 35% less volatile than the S&P 500. Comparatively, Kingsoft Cloud has a beta of 2.15, suggesting that its stock price is 115% more volatile than the S&P 500.

Summary

Kingsoft Cloud beats Portage Biotech on 8 of the 15 factors compared between the two stocks.

About Portage Biotech

(Get Free Report)

Portage Biotech Inc., together with its subsidiaries, researches and develops pharmaceutical and biotechnology products. The company’s product includes IMM60, an iNKT cell activator; IMM65, a PLGA-nanoparticle combined with a NY-ESO-1 peptide vaccine; INT230-6 that is in Phase I/II clinical trials for the treatment of solid tumors; STING, a small molecule that binds to the stimulator of interferon genes in cancer; CellPorter, a cell permeable peptide platform technology derived from human proteins; PPL-003, an ophthalmic solution; and SBI-101, a blood-conditioning technology to restore balance to the immune system after acute vital organ injury, such as acute kidney injury. It also focuses on nanolipogel technology for use in immune-oncology; and antibodies against a novel T-cell for use as a monotherapy and combination therapy for solid and haematological malignancies. In addition, the company develops antibodies implicated in the inflammatory tumor and tumor-infiltrating immune cell microenvironments; and FOXO4-P53 modulator and C-RAF inhibitor. Portage Biotech Inc. is based in Tortola, British Virgin Islands.

About Kingsoft Cloud

(Get Free Report)

Kingsoft Cloud Holdings Limited provides cloud services to businesses and organizations primarily in China. The company's products portfolio includes cloud products, including infrastructure as a service (IaaS) infrastructure, platform as a service (PaaS) middleware, and software as a service (SaaS) applications that primarily consist of cloud computing, network, database, big data, security, storage, and delivery solutions. It offers research and development services, as well as enterprise digital solutions and related services. The company also provides public cloud services to customers in various verticals, including video, e-commerce, intelligent mobility, artificial intelligence, and mobile internet; and enterprise cloud services to customers in financial services, public service, and healthcare businesses. Kingsoft Cloud Holdings Limited was incorporated in 2012 and is headquartered in Beijing, the People's Republic of China.

Receive News & Ratings for Portage Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Portage Biotech and related companies with MarketBeat.com's FREE daily email newsletter.